Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Adverum Biotechnlgs (ADVM)

Adverum Biotechnlgs (ADVM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 233,085
  • Shares Outstanding, K 97,935
  • Annual Sales, $ 0 K
  • Annual Income, $ -117,510 K
  • 60-Month Beta 1.20
  • Price/Sales 27.58
  • Price/Cash Flow N/A
  • Price/Book 0.55
Trade ADVM with:

Options Overview

Details
  • Implied Volatility 59.43%
  • Historical Volatility 97.75%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 212.45% on 10/02/20
  • IV Low 59.43% on 07/30/21
  • Put/Call Vol Ratio 0.02
  • Today's Volume 2,781
  • Volume Avg (30-Day) 2,885
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 67,993
  • Open Int (30-Day) 49,677

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.37
  • Number of Estimates 4
  • High Estimate -0.30
  • Low Estimate -0.41
  • Prior Year -0.36
  • Growth Rate Est. (year over year) -2.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.26 +0.67%
on 07/23/21
3.66 -37.98%
on 07/12/21
-1.23 (-35.14%)
since 06/30/21
3-Month
2.26 +0.67%
on 07/23/21
4.06 -44.09%
on 05/03/21
-1.63 (-41.79%)
since 04/30/21
52-Week
2.26 +0.67%
on 07/23/21
19.25 -88.21%
on 08/07/20
-15.39 (-87.15%)
since 07/30/20

Most Recent Stories

More News
Bionano (BNGO) to Report Q2 Earnings: What's in the Cards?

Bionano Genomics (BNGO) is likely to provide updates on earnings and revenues when it reports second-quarter 2021 results.

DVAX : 9.34 (-1.58%)
ADVM : 2.27 (-4.62%)
CRVS : 2.09 (-3.24%)
BNGO : 5.93 (-2.63%)
Vectorized Antibodies for In Vivo Expression Industry - Featuring Adverum Biotechnologies, Homology Medicines and BioNTech Among Others

The "Vectorized Antibodies for In Vivo Expression by DNA and mRNA: A Landscape Analysis Of Stakeholders, Technologies, Targets, Business and Financing from an Industry Perspective" report has been added...

ADVM : 2.27 (-4.62%)
Adverum Announces Appointment of Jon Williams, Ph.D., as Vice President, Clinical Affairs

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the appointment of Jon Williams, Ph.D., as...

ADVM : 2.27 (-4.62%)
Adverum Biotechnologies (ADVM) Moves to Buy: Rationale Behind the Upgrade

Adverum Biotechnologies (ADVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ADVM : 2.27 (-4.62%)
Are Options Traders Betting on a Big Move in Adverum (ADVM) Stock?

Investors need to pay close attention to Adverum (ADVM) stock based on the movements in the options market lately.

ADVM : 2.27 (-4.62%)
Dr. Reddy's (RDY) Q4 Earnings Decline Y/Y, Sales Increase

Dr. Reddy's (RDY) earnings decline while sales grow year over year in fourth-quarter fiscal 2021.

RDY : 62.55 (-1.17%)
ADPT : 36.66 (+0.14%)
ADVM : 2.27 (-4.62%)
MIST : 5.70 (+4.20%)
Adverum Biotechnologies (ADVM) is Oversold: Can It Recover?

Adverum Biotechnologies (ADVM) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

ADVM : 2.27 (-4.62%)
The Sonic Fund II, L.P. Comments on Preliminary Voting Results of Adverum Annual Meeting

--Believes Company Cannot Continue to Pursue Status Quo Strategy, Which Has Been Abjectly Discredited

ADVM : 2.27 (-4.62%)
Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual Meeting

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that, based on a preliminary vote count provided...

ADVM : 2.27 (-4.62%)
The Sonic Fund II, L.P. Issues Statement to Adverum Stockholders

The Sonic Fund II, L.P. ("Sonic"), which beneficially owns approximately 6.8% of the outstanding common stock of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) (the "Company" or "Adverum"), today issued...

ADVM : 2.27 (-4.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum's core capabilities include clinical development,...

See More

Key Turning Points

3rd Resistance Point 2.58
2nd Resistance Point 2.51
1st Resistance Point 2.39
Last Price 2.27
1st Support Level 2.21
2nd Support Level 2.14
3rd Support Level 2.02

See More

52-Week High 19.25
Fibonacci 61.8% 12.76
Fibonacci 50% 10.75
Fibonacci 38.2% 8.75
Last Price 2.27
52-Week Low 2.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar